These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8991644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T.
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [Abstract] [Full Text] [Related]

  • 4. A recombinant immunoblot and ELISA for detection of acute parvovirus B19 infection.
    Schwarz TF, Jäger G.
    Zentralbl Bakteriol; 1994 Mar; 280(4):526-33. PubMed ID: 8061414
    [Abstract] [Full Text] [Related]

  • 5. Impaired gamma interferon responses against parvovirus B19 by recently infected children.
    Corcoran A, Doyle S, Waldron D, Nicholson A, Mahon BP.
    J Virol; 2000 Nov; 74(21):9903-10. PubMed ID: 11024117
    [Abstract] [Full Text] [Related]

  • 6. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A, Manaresi E, Zakrzewska K, DeSantis R, Musiani M, Zerbini M.
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [Abstract] [Full Text] [Related]

  • 7. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
    Gray JJ, Cohen BJ, Desselberger U.
    J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
    [Abstract] [Full Text] [Related]

  • 8. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
    Manaresi E, Zuffi E, Gallinella G, Gentilomi G, Zerbini M, Musiani M.
    J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
    [Abstract] [Full Text] [Related]

  • 9. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.
    Salimans MM, van Bussel MJ, Brown CS, Spaan WJ.
    J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069
    [Abstract] [Full Text] [Related]

  • 10. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC.
    J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
    [Abstract] [Full Text] [Related]

  • 11. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S, O'Keeffe G, Kilty C, Doyle S.
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
    Bostic JR, Brown KE, Young NS, Koenig S.
    J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
    [Abstract] [Full Text] [Related]

  • 13. Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay.
    Söderlund M, Brown KE, Meurman O, Hedman K.
    J Clin Microbiol; 1992 Feb; 30(2):305-11. PubMed ID: 1537897
    [Abstract] [Full Text] [Related]

  • 14. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA, Leslie EE, Smith S, O'Neill HJ, Hart H, Cohen BJ, Inglis JM.
    J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
    [Abstract] [Full Text] [Related]

  • 15. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W, Halim MA, Al-Nakib W.
    Virology; 2009 Jul 20; 390(1):56-63. PubMed ID: 19450862
    [Abstract] [Full Text] [Related]

  • 16. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
    Kerr JR, Coyle PV, DeLeys RJ, Patterson CC.
    J Med Virol; 1996 Jan 20; 48(1):68-75. PubMed ID: 8825713
    [Abstract] [Full Text] [Related]

  • 17. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.
    Manaresi E, Gallinella G, Zerbini M, Venturoli S, Gentilomi G, Musiani M.
    J Med Virol; 1999 Feb 20; 57(2):174-8. PubMed ID: 9892404
    [Abstract] [Full Text] [Related]

  • 18. Antibody responses in parvovirus B19 infected patients.
    Modrow S, Dorsch S.
    Pathol Biol (Paris); 2002 Jun 20; 50(5):326-31. PubMed ID: 12116851
    [Abstract] [Full Text] [Related]

  • 19. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
    Lehmann HW, Kühner L, Beckenlehner K, Müller-Godeffroy E, Heide KG, Küster RM, Modrow S.
    J Clin Virol; 2002 Aug 20; 25(2):135-43. PubMed ID: 12367647
    [Abstract] [Full Text] [Related]

  • 20. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
    Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F.
    AIDS; 1992 Jul 20; 6(7):679-84. PubMed ID: 1503687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.